Oakworth Capital, Inc. Takeda Pharmaceutical CO LTD Transaction History

Oakworth Capital, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 20, 2021	SELL	$16.55 - $18.64 $203,614 - $229,327	-12,303 Reduced 94.29%	745 $13,000
Q4 2019 Jan 31, 2020	SELL	$16.88 - $20.83 $26,417 - $32,598	-1,565 Reduced 10.71%	13,048 $256,000
Q1 2019 May 06, 2019	BUY	$16.7 - $21.52 $244,037 - $314,471	14,613 New	14,613 $298,000

338

76.2M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Oakworth Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Oakworth Capital, Inc. with notifications on news.